CD86与犬囊细胞肉瘤的亡有关
Benjamin Diehl1, Andreas Kirchhoff2, Florian Hansmann1
1Faculty of Veterinary Medicine, Institute of Veterinary Pathology, Leipzig University, Leipzig, Germany.
Frontiers in veterinary science
|April 24, 2025
概括
这项研究探讨了犬类囊性肉瘤 (HS) 中的CD80和CD86免疫检查点蛋白,发现CD86和瘤细胞死亡之间存在联系. 这项研究还确定了干扰素路径标记物,这表明它在这种狗癌症的免疫逃避中发挥了作用.
科学领域:
- 免疫学 免疫学 免疫学
- 兽医瘤学 兽医瘤学
- 癌症研究 癌症研究
背景情况:
- 免疫检查点,包括CD80和CD86,对于调节抗瘤免疫力至关重要.
- 以前的研究表明CD80/CD86参与了犬类皮肤囊细胞瘤回归.
- 与GTPase 1 (Mx1) 一样被MX激素标记的干扰素通路,与癌症免疫逃避有关.
研究的目的:
- 为了研究CD80和CD86在犬囊细胞肉瘤 (HS) 中的表达和作用.
- 为了阐明干扰素-I途径在HS中的状态.
- 探索免疫检查点表达和瘤细胞死亡标志物之间的潜在相关性.
主要方法:
- 对15只狗的皮肤,肺和肝脏的22个HS组织样本进行了免疫组织化学检查.
- 针对CD80,CD86的抗体,编程死亡配体1 (PD-L1),幸存者,切割的caspase-3 (Casp-3),干扰素基因刺激器 (STING) 和Mx1.
- 幻灯片被数字化并使用QuPath进行分析以进行定量评估.
主要成果:
- 在CD86和Casp-3表达细胞之间观察到正相关性,这表明CD86在瘤细胞死亡中的作用.
- 皮肤和肺部HS的CD80表达率高于CD86,而肝脏HS的水平相似.
- 在瘤细胞上检测到低PD-L1表达;Mx1和STING在瘤细胞中表达,表明干扰素通路激活.
结论:
- CD86可能在诱导狗囊性肉 Sarcoma 的细胞死亡中发挥作用.
- 在HS中存在CD80和CD86表达的显著器官特异性差异.
- 干扰素I型路径标记物的存在表明它们参与了犬类HS的免疫逃避机制.
关键词:
CD8080 CD8080 CD8080 CD8080 CD8080 CD80 CD80 CD80 CD80 CD80 CD80 CD80 CD80 CD80 CD80 CD80 CD80 CD80 CD80 CD80 CD80 CD80 CD80 CD80 CD80 CD80 CD80 CD80 CD80CD86 CD86 CD86 CD86 CD86 CD86 CD86 CD86 CD86 CD86 CD86 CD86 CD86 CD86 CD86 CD86 CD86 CD86 CD86狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗囊细胞性肉瘤 (histiocytic sarcoma) 是一种囊细胞性肉瘤.免疫检查点是一个检查点.mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1mx1幸存者 幸存者 幸存者相关概念视频
The Intrinsic Apoptotic Pathway
5.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.6K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Phagocytosis of Apoptotic Cells
3.1K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...
Normal cells contain receptors that prevent them from being recognized...
3.1K
The Extrinsic Apoptotic Pathway
5.5K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
5.5K


